Items where Division is "03 Faculty of Medicine > Departement Biomedizin > Department of Biomedicine, University Hospital Basel > Translational Diabetes (Cavelti-Weder)"
Number of items at this level: 3. 2016Cavelti-Weder, C. and Li, W. and Zumsteg, A. and Stemann-Andersen, M. and Zhang, Y. and Yamada, T. and Wang, M. and Lu, J. and Jermendy, A. and Bee, Y. M. and Bonner-Weir, S. and Weir, G. C. and Zhou, Q.. (2016) Hyperglycaemia attenuates in vivo reprogramming of pancreatic exocrine cells to beta cells in mice. Diabetologia, 59 (3). pp. 522-532. Cavelti-Weder, C. and Timper, K. and Seelig, E. and Keller, C. and Osranek, M. and Lassing, U. and Spohn, G. and Maurer, P. and Muller, P. and Jennings, G. T. and Willers, J. and Saudan, P. and Donath, M. Y. and Bachmann, M. F.. (2016) Development of an Interleukin-1β Vaccine in Patients with Type 2 Diabetes. Molecular Therapy, 24 (5). pp. 1003-1012. 2015Yamada, Takatsuga and Cavelti-Weder, Claudia and Caballero, Francisco and Lysy, Philippe A. and Guo, Lili and Sharma, Arun and Li, Weida and Zhou, Qiao and Bonner-Weir, Susan and Weir, Gordon C.. (2015) Reprogramming Mouse Cells With a Pancreatic Duct Phenotype to Insulin-Producing β-Like Cells. Endocrinology, 156 (6). pp. 2029-2038. |
